ABBOTT PRISMnEXT

 

 

PROCESS AUTOMATION

 The ABBOTT PRISMnEXT enhances process automation and cGMP compliance and offers a comprehensive menu of blood screening assays.

For in vitro diagnostic use only.

 The ABBOTT PRISMnEXT provides automated processes that deliver high throughput, walk-away testing protocols.

 

REFER TO THE OPERATIONS MANUAL OR USER GUIDE FOR WARNINGS, PRECAUTIONS AND LIMITATIONS FOR PROPER USE OF THE INSTRUMENT. 


REGISTER OR LOGIN TO YOUR ACCOUNT TO VIEW ASSAY SPECIFIC PACKAGE INSERTS FOR INTENDED USE AND IMPORTANT SAFETY INFORMATION.
Test Menu
System Specifications
 
   
Assay technology Chemiluminescent immunoassay
Sample Types Serum, Plasma
Assay channels 4 or 6 (Channels are configured for specific
assays during installation by an Abbott
representative.)
Sample racks 28 positions per rack
Maximum 10 racks*
Reaction trays 16 reaction cells per tray
Maximum loading: 27 trays per tray loader*
Sample dispense
volume
50-100 μL ± 10%
System control
center
VGA-compatible color monitor with
keyboard
Dimensions
(HxWxD)
68” x 91.6” x 33.1”
1.73 x 2.33 x .84 m
Weight 1660 lb
753 kg
Uninterruptible
power supply
Single phase 200-240 VAC ± 10%

Footnote:
*Continuous access
ABBOTT PRISMnEXT SYSTEM INTENDED USE AND IMPORTANT SAFETY INFORMATION

 

Intended Use

The ABBOTT PRISMnEXT is an automated immunoassay analyzer designed to perform Chemiluminescent Immunoassay (ChLIA) technology. The ABBOTT PRISMnEXT performs batch/continuous access and STAT processing of specimens containing both large and small molecular weight analytes. 

 

Usage and Safety Information 

System operators must be aware of both biohazardous risks and risks inherent in operating electromechanical equipment and are responsible for using the system only as designed. Failure to follow safe use instructions could cause injury to the operator, damage to the system, or adversely affect assay results.

 
 
 
 
INTENDED USE AND IMPORTANT SAFETY INFORMATION 

For In Vitro Diagnostic Use Only

 

Caution: United States Federal Law restricts these devices to sale and distribution by or on the order of a physician, or to a clinical laboratory; and use is restricted to, by, or on the order of a physician. These products contain human-sourced and/or potentially infectious components and must be handled in accordance with the OSHA Standard on Bloodborne Pathogens.

 

For complete assay information, see the assay specific package insert.

 

ABBOTT PRISM CHAGAS

Intended Use: The ABBOTT PRISM Chagas assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to Trypanosoma cruzi (T cruzi), the causative agent of Chagas disease, in human serum and plasma specimens. The ABBOTT PRISM Chagas assay is intended to screen individual human donors, including volunteer donors of whole blood and blood components and other living donors, for the presence of antibodies to T cruzi. The assay is also intended for use in testing serum and plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating, and in testing blood specimens to screen cadaveric (non–heart-beating) donors. It is not intended for use on cord blood specimens.


Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of T cruzi infection.

 

ABBOTT PRISM HIV O PLUS

Intended Use: The ABBOTT PRISM HIV O Plus assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to HIV-1 (anti-HIV-1) Groups M and O and/or antibodies to HIV-2 (anti-HIV-2) in human serum and plasma specimens. The ABBOTT PRISM HIV O Plus assay is intended to screen individual human donors, including volunteer donors of Whole Blood and blood components and other living donors, for the presence of anti-HIV-1 Groups M and O and/or anti-HIV-2. The assay is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating, in testing blood specimens to screen cadaveric (non–heart-beating) donors, and as an aid in the diagnosis of HIV-1/HIV-2 infection. It is not intended for use in testing cord blood specimens.


Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way.

 

ABBOTT PRISM HEPATITIS B VIRUS CORE ANTIGEN

Intended Use: The ABBOTT PRISM HBcore assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of total antibody to hepatitis B core antigen (anti-HBc) in human serum and plasma specimens. The product is intended to screen individual human donors, including volunteer donors of whole blood and blood components, and other living donors to prevent transmission of hepatitis B virus (HBV) from such donors. It is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor's heart is still beating. It is not intended for use on cord blood specimens.


Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of HBV infection. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe wa.

 

ABBOTT PRISM HEPATITIS B SURFACE ANTIGEN

Intended Use: The ABBOTT PRISM HBsAg assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of hepatitis B surface antigen (HBsAg) in human serum and plasma specimens. The ABBOTT PRISM HBsAg (ChLIA) is intended to screen individual human donors, including volunteer donors of whole blood and blood components, and other living donors for the presence of HBsAg. It is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating, and in testing blood specimens to screen cadaveric (non-heart-beating) donors. It is not intended for use on cord blood specimens.


Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of HBV infection. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way.

 

ABBOTT PRISM HBSAG CONFIRMATORY

Intended Use: The ABBOTT PRISM HBsAg Confirmatory assay is an in vitro qualitative chemiluminescent immunoassay (ChLIA) used to confirm the presence of hepatitis B surface antigen (HBsAg) in human serum and plasma by means of specific antibody neutralization. The ABBOTT PRISM HBsAg Confirmatory assay is intended to be used for confirmation of samples found to be repeatedly reactive by the ABBOTT PRISM HBsAg assay.

 

Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of HBV infection. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way.

 

ABBOTT PRISM HCV

Intended Use: The ABBOTT PRISM HCV assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to hepatitis C virus (anti‑HCV) in human serum and plasma specimens. The ABBOTT PRISM HCV (ChLIA) is intended to screen individual human donors, including volunteer donors of whole blood and blood components, and other living donors for the presence of anti-HCV. It is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor's heart is still beating, and in testing blood specimens to screen cadaveric (non-heart beating) donors. It is not intended for use on cord blood specimens.

 

Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of HCV infection. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way.

 

ABBOTT PRISM HTLV‑I/HTLV‑II

Intended Use: The ABBOTT PRISM HTLV‑I/HTLV‑II assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to human T‑lymphotropic virus Type I and/or human T‑lymphotropic virus Type II (anti‑HTLV‑I/HTLV‑II) in human serum and plasma specimens. The ABBOTT PRISM HTLV-I/HTLV-II (ChLIA) is intended to screen individual human donors, including volunteer donors of whole blood and blood components, and other living donors for the presence of anti-HTLV-I/HTLV-II. It is also intended for use in testing blood and plasma specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating. It is not intended for use on cord blood specimens.

 

Important Safety Information: Package insert instructions must be carefully followed. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in the package insert. The performance characteristics of this product have not been established for the laboratory diagnosis of HTLV-I/HTLV-II infection. This product contains sodium azide. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way.

 
 
 
 

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE TRANSFUSION WEBSITE?

Content is not under the control of transfusion.abbott.

Yes No